Vasten

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vasten

Property Description
Active ingredient Pravastatin sodium
Form Tablet (oral dosage form)
Pharmacological class HMG-CoA Reductase Inhibitor (Statin)
General purpose Lipid-lowering agent
Origin Synthetic compound

Vasten: Defining the Statin Class and Active Ingredient

Vasten is a prescription-only, synthetic medication classified as a statin, used primarily to regulate blood lipid levels. Its active chemical entity is Pravastatin sodium, a compound designed to modify the body's cholesterol production. Vasten is pharmacologically defined as an HMG-CoA Reductase Inhibitor, placing it within a crucial group of medicines recognized globally as the standard for managing elevated cholesterol. Pravastatin is structurally classified as a water-soluble (hydrophilic) statin, which affects its distribution within the body. This hydrophilic property is a key differentiating factor that distinguishes Pravastatin from other members of the statin class. The fact that it is a statin means the drug operates by specifically targeting and blocking a key enzyme involved in the body's internal synthesis of cholesterol, a mechanism clinically recognized for efficacy in lowering lipid levels.


Composition, Pharmaceutical Form, and Origin

The primary active ingredient in Vasten is Pravastatin sodium, delivered as a single-agent oral tablet. It is formulated as a solid oral dosage form, meaning it is swallowed to be absorbed into the systemic circulation. Vasten is a single-agent product; it contains only Pravastatin sodium as the main therapeutic component, formulated alongside inert solid excipients necessary to create the stable tablet structure. The active compound is classified as synthetic, derived from biological sources and refined through a chemical process to achieve its final therapeutic structure. This precise composition ensures standardized, predictable absorption when taken by patients.


General Therapeutic Role and Purpose

The general purpose of Vasten is to act as a hypolipidemic agent, reducing unhealthy levels of cholesterol in the blood. The drug works by controlling the liver's production of LDL cholesterol (often referred to as “bad” cholesterol) and simultaneously enhancing the liver's capacity to remove existing LDL from the bloodstream. This physiological action specifically targets high lipid levels, which is the primary benefit, establishing the drug's role in the management of hypercholesterolemia. This class of medication is recognized for effectively reducing the risk of cardiovascular events through its lipid-lowering action. This indicates that Vasten plays a central role in helping patients manage lipid abnormalities that pose a long-term risk to heart and vessel health.

Regulatory References

  1. U.S. National Library of Medicine

What side effects are possible with Vasten?

Possible Side Effects and Safety Information

The following section summarizes officially documented side effects and safety considerations for Vasten (Valsartan), based on governmental regulatory documents.

Adverse Reaction Category Examples and Regulatory Classifications
Common Adverse Reactions Headache, dizziness, fatigue, diarrhea, back pain, arthralgia, and upper respiratory tract or viral infections (incidence typically ge 1% and often ge placebo).
Serious Adverse Reactions Angioedema (swelling of face, lips, or throat), symptomatic hypotension (excessively low blood pressure), hyperkalemia (high potassium levels), and renal function impairment, which can include acute renal failure.
System-Organ Classes The effects primarily involve the nervous system, vascular system, renal/urinary system, metabolism, and musculoskeletal system.

Population-Specific and High-Level Safety Notes

Pregnancy and Fetal Toxicity: Vasten is subject to a Boxed Warning regarding use in pregnancy. It must be discontinued as soon as pregnancy is detected, as drugs acting on the renin-angiotensin system can cause injury and death to the developing fetus, particularly in the second and third trimesters.

Special Patient Considerations: Use requires caution in patients with impaired renal function, severe congestive heart failure, or volume/salt depletion, as these conditions increase the risk of adverse renal effects or symptomatic hypotension. Monitoring of renal function and serum potassium is advised for susceptible patients. The drug is contraindicated in patients with a history of angioedema related to Vasten or other Angiotensin II Receptor Blockers (ARBs).

Overdose and Emergency Response

The official regulatory documentation for Vasten (Pravastatin sodium) notes that clinical experience detailing acute overdosage in humans is limited. The manifestations of significant overexposure are anticipated to align closely with the drug’s known severe adverse reactions, which primarily affect the muscles and liver.

Documented Overdose Manifestations

Overdosage may be characterized by signs consistent with myopathy, potentially including unexplained muscle pain, tenderness, or weakness. Severe high-exposure scenarios can escalate to the serious, life-threatening condition of rhabdomyolysis, which may cause resultant acute kidney injury. Signs of potential liver damage, such as jaundice, dark urine, or upper right abdominal pain, are critical manifestations that require urgent evaluation. Population groups with renal impairment, uncontrolled hypothyroidism, or those of advanced age are noted in official labeling as having predisposing risk factors for severe muscle toxicity, which warrants intensified monitoring during any high-exposure incident.

Emergency Actions and Management

Immediate medical attention is formally required upon suspicion of Vasten overdosage. Regulatory guidance mandates contacting a Poison Control Center and calling emergency services (such as 911 or the local equivalent) if the exposed individual has collapsed, has trouble breathing, or is unresponsive. Management is strictly symptomatic and supportive, as no specific antidote is known for Pravastatin. Officially described procedures include the immediate discontinuation of Vasten therapy and close monitoring of serum Creatine Phosphokinase (CK) and hepatic transaminase (ALT/AST) levels to assess the extent of muscle and liver involvement.

Therapeutic Uses of Vasten

What Vasten Treats: Main Uses and Benefits

Vasten is commonly applied across domains where additional symptomatic support is needed. It is relevant in contexts involving increased discomfort or tension and may be part of symptomatic management for conditions where functional stability becomes affected.

The medication is generally used in situations involving certain distressing symptoms, including those that interfere with daily functioning and symptoms that create noticeable physiological strain. It is applied when supportive symptom management is appropriate for conditions characterized by periods of heightened symptoms and recurrent or episodic manifestations.

It offers symptomatic relief that helps patients cope more steadily with difficult episodes, and contributes to easing the overall symptom load. It assists with maintaining a sense of stability when symptoms become more noticeable.

“This class of medication supports patients during difficult episodes by easing distress and contributing to improved day-to-day comfort during symptomatic periods.”

Quick Fact: Relevant for Symptoms that Interfere with Daily Functioning

Vasten is relevant in clinical settings marked by increased discomfort or tension and is used across areas where short-term symptom stabilization is important.

Regulatory References

  1. NIH MedlinePlus overview of this class of medication

Eligibility and Restrictions for Use

Vasten (Pravastatin sodium) eligibility is strictly defined by regulatory documents, specifying populations for whom use is prohibited, restricted, or established.

Contraindicated Populations

Use is prohibited for patients with:

  • Active Liver Disease, including unexplained, persistent elevations of serum transaminases (liver enzymes).
  • Known hypersensitivity to Pravastatin or any component of the medication.
  • Pregnancy or for women who may become pregnant, and lactating women (nursing mothers).

Age-Group and Condition Restrictions

Population Group Regulatory Status
Children under 8 years Safety and efficacy not established.
Pediatric patients ge 8 years Approved for heterozygous familial hypercholesterolemia (HeFH).
Older Adults (ge 65 years) Permitted, but caution is required due to advanced age being a predisposing factor for muscle toxicity.
Severe Renal Impairment Use requires special consideration and monitoring.
Myopathy Risk Factors Caution required for patients with uncontrolled hypothyroidism, a history of alcohol abuse, or hereditary muscular disorders.

Official labeling also states that Vasten has not been evaluated in patients with Homozygous Familial Hypercholesterolemia (HoFH).

The final eligibility structure dictates that use is determined by ruling out specific organ impairment and reproductive status, and by confirming age and medical history align with regulatory guidelines.

What should I know about interactions with other medicines?

Vasten Interactions with other medicines and products

The regulatory interaction profile for Vasten (Pravastatin sodium) is defined by officially documented pharmacokinetic and pharmacodynamic interactions. Co-administration with certain medicinal products requires dose restrictions or timing separation to manage the risk of increased exposure or additive adverse effects.

Documented Interaction Restrictions

Interacting Substance/Class Official Interaction Outcome/Restriction
Gemfibrozil Use must be avoided due to the significantly increased risk of myopathy and rhabdomyolysis.
Cyclosporine Increases Vasten exposure (AUC). Maximum Vasten dose is limited to 20 mg daily.
Clarithromycin / Erythromycin Increases Vasten exposure. Maximum Vasten dose is limited to 40 mg daily.
Resmetirom (REZDIFFRA) Increases Vasten exposure. Maximum Vasten dose is limited to 40 mg daily.
Bile Acid Sequestrants (e.g., Cholestyramine) Requires timing separation: Administer Vasten at least one hour before or four hours after the sequestrant.
Niacin (ge 1 g/day) or Colchicine Increases the documented risk of adverse skeletal muscle effects.

Population-specific notes highlight that advanced age (ge 65 years) and renal impairment are predisposing factors that increase the susceptibility to interaction-related skeletal muscle effects. While Vasten has no clinically significant interaction with food, official sources indicate that substantial consumption of alcohol may increase the documented risk of liver damage.

Mechanism of Action

How Vasten Works

The mechanism of Vasten (Pravastatin) is highly targeted, focusing exclusively on two integrated domains within the liver to modulate the concentration of circulating lipoproteins.


Inhibition of Hepatic Cholesterol Synthesis

The primary action involves competitive inhibition of the enzyme HMG-CoA Reductase within liver cells. This molecular blockade arrests the rate-limiting step in the mevalonate pathway, suppressing the liver’s ability to produce its own cholesterol supply. Because of Vasten’s hydrophilic structure, this inhibitory action is largely restricted to the liver, leading to action primarily confined to the liver.


Mechanistic Cascade for Lipoprotein Clearance

The reduction of internal cholesterol triggers a compensatory signaling cascade, forcing the liver to significantly increase the number of LDL receptors on its surface. These elevated receptors efficiently bind and clear circulating LDL from the plasma, increasing the catabolism of low-density lipoproteins. This two-part mechanism—inhibition followed by receptor upregulation—is the biological process that results in the systemic modulation of circulating lipoprotein concentrations.

Dosage and Administration Information

Vasten (simvastatin) is prescribed as an adjunct to diet, exercise, and weight loss to reduce the risk of cardiovascular events and to lower elevated cholesterol levels.

Dosage and Administration

Dosage Form Timing Important Instructions
Tablets Once daily, in the evening. Swallow the tablet whole with water. May be taken with or without food.
Oral Suspension Once daily, in the evening, on an empty stomach. Shake the bottle well for at least 20 seconds before use. Measure the dose accurately with a marked device.

The typical adult dosage range is 20 mg to 40 mg once daily. The maximum recommended dose is generally 40 mg daily. The 80 mg dose is restricted only to patients who have been taking it chronically for 12 months or more without muscle toxicity, as the risk of myopathy is increased at this strength. Your physician will individualize the dose based on your condition, cholesterol levels, and response to treatment. Dosage may be adjusted after four weeks of therapy and periodically thereafter.

Critical Precautions

  • Do not consume grapefruit or grapefruit juice in large quantities while taking Vasten, as it can increase the concentration of the medication in your blood and raise the risk of side effects.
  • If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule; do not take a double dose to catch up.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Vasten (Pravastatin)

The overview of studies for Vasten summarizes research findings from large-scale, controlled clinical trials and meta-analyses that constitute the main evidence base. This description is based on what research was conducted and what event patterns were observed, without offering individual medical advice or making claims about predictable personal outcomes.


Evidence for Primary Prevention of Major Cardiac Events

The research base includes large-scale Randomized Controlled Trials (RCTs) that compared Vasten against a control group in individuals with elevated lipid levels but no history of a cardiac event. These studies typically followed participants for durations ranging from four to six years. Key measurements monitored were the first occurrence of events such as nonfatal Myocardial Infarction (MI), Coronary Heart Disease (CHD) death, and the need for revascularization procedures. Studies report the frequency of these events in the group studied with Vasten compared to the control group.

Evidence Following a Cardiac Event (Secondary Prevention)

For patients with a history of a cardiac event, evidence is based on large, placebo-controlled RCTs that monitored outcomes over observation periods averaging five to six years. These studies explored whether the use of Vasten was associated with differences in the rate of total mortality, cardiovascular mortality, recurrent MI, and stroke. Analyses reported the measured frequency of these events across the different study groups, including subgroups with co-existing conditions like diabetes.

Research Gaps and Uncertainties

Scientific literature notes areas where data remain insufficient. For instance, data for patients with severe chronic kidney disease or complex metabolic conditions were often not included in the primary RCTs. Additionally, long-term clinical outcome data (e.g., cardiovascular events in adulthood) for children and adolescents studied with Heterozygous Familial Hypercholesterolemia (HeFH) are not fully established due to limited follow-up durations.

Frequently Asked Questions (FAQ)

Common questions about Vasten (FAQ)


Q: How long does it typically take to notice the effects of Vasten?

Regulatory information indicates Vasten begins its biological action after the first dose. However, official information shows that significant changes in cholesterol levels may take one or more weeks to be fully observed. Official guidelines note that a healthcare professional may assess a patient’s response over a period of weeks or months.


Q: Are there any long-term effects of using Vasten?

Vasten is typically part of a long-term treatment plan, with benefits generally continuing while the medicine is used. Official safety data indicates that long-term use is associated with the need for monitoring for potential serious side effects, such as muscle issues (myopathy) or changes in liver function.


Q: Can Vasten affect my mood or energy levels?

Official safety data has reported side effects that may affect the nervous system, including headache, dizziness, fatigue, and sleep disturbances like insomnia or nightmares. Changes in mood, such as depression, are reported in official safety data with an unknown frequency.


Q: How is Vasten different from other similar medicines I've heard of?

Vasten belongs to the statin class of medicines, which all work to lower cholesterol. The official classification describes the active ingredient, Pravastatin sodium, as a water-soluble statin, which is one of the ways it differs from other statins in the class.


Q: Does Vasten cause weight gain or weight loss?

Weight change is generally not listed as a common side effect in official regulatory documents. Commonly reported adverse reactions, such as fatigue or muscle weakness, are generally not linked to weight change in regulatory documents.


Q: Are there any specific foods or drinks to avoid while on Vasten?

Official labeling generally indicates that Vasten does not have clinically significant interactions with food. The specific exception is grapefruit or grapefruit juice, as official information indicates substantial consumption can increase medicine concentration and raise the risk of side effects.


Q: Is Vasten a long-term or short-term treatment?

Vasten is typically prescribed as a long-term treatment that may be taken for many months or years. Studies indicate that the cardiovascular benefits, such as the reduction of risk for heart events, generally only continue for as long as the medication is used.


Q: Will Vasten interfere with my ability to get vaccinated?

Official regulatory documents focus primarily on drug-to-drug interactions. General interaction with vaccines is not a documented clinical problem. Official information emphasizes that all substances and treatments, including recent or planned vaccinations, should be discussed with a healthcare professional.


Q: Is Vasten the same as other similar medicines I've heard of?

No. Vasten's active ingredient, Pravastatin, is one of several distinct medicines in the statin class. While they share a common cholesterol-lowering action, they are distinct compounds with different chemical structures and regulatory profiles.


Q: Why do some people say Vasten didn't work for them?

Vasten's dose is individualized and adjusted over time based on a patient’s specific response. Official documents note that the measured effectiveness of Vasten can be influenced by factors such as consistency of use, changes in diet and exercise, and the use of other concurrent medications.


Q: Is Vasten safe for older adults or seniors?

Vasten is permitted for use in older adults (ages 65 and over). Official documents acknowledge that advanced age is cited as a documented risk factor for muscle toxicity, and these factors are taken into consideration during prescribing.


Q: Is it normal to feel a bit unwell when first starting Vasten?

Official documents list headache, diarrhea, nausea, stomach pain, and fatigue as common adverse reactions, which often occur when first starting a medicine. Official documents note that side effects sometimes improve over time as the body adjusts to the medication.


Q: Does Vasten need to be taken at a specific time of day?

Official regulatory documents typically recommend taking Vasten once a day in the evening. This recommendation aligns with the body's natural cholesterol synthesis cycle.


Q: Can Vasten be taken with vitamins or herbal supplements?

Interactions can occur with supplements; for instance, the regulatory information mentions a known interaction with niacin. Official information states that all products being taken, including vitamins and herbal supplements, should be reviewed by a healthcare professional to identify potential interactions.


Q: Is Vasten a common drug or a newer one?

Vasten (Pravastatin) belongs to the statin class of medicines. This is a well-established and widely used group of treatments globally recognized as a standard approach for managing elevated cholesterol levels.


Q: Does Vasten affect fertility or reproductive health?

Vasten is contraindicated, meaning its use is prohibited, in women who are pregnant or nursing. Official labeling states that if a patient becomes pregnant, their healthcare professional should be notified immediately.


Q: Can I drive or operate machinery while using Vasten?

Vasten generally does not interfere with the ability to drive or operate machinery. However, due to the potential for side effects like dizziness, regulatory documents indicate that patients should be aware of how the medicine affects them before engaging in activities that require mental alertness.


Q: What is the shelf life or proper storage for Vasten?

Official documents specify that Vasten must be stored at controlled room temperature (typically 20 C to 25 C). It is critical that the container remains tightly closed and the contents are protected from moisture and light.


Q: Why are there warnings about Vasten and pre-existing heart conditions?

Vasten is used to reduce cardiovascular risk. However, official safety notes highlight that patients with specific conditions like severe congestive heart failure are at an increased risk for certain adverse effects, such as symptomatic low blood pressure. The prescribing of Vasten involves an assessment of the risks and potential benefits, as with any medication.


Q: Is Vasten suitable for use by adolescents?

Official regulatory documents indicate that Vasten is approved for use in pediatric patients aged 8 years and older. This use is specifically for a cholesterol condition called heterozygous familial hypercholesterolemia (HeFH). Safety and efficacy have not been established for children under 8 years of age.


Q: Can Vasten be split in half if needed?

Official regulatory or patient information should be consulted to confirm if a tablet is designed to be split. Altering the form of the tablet is described as having a potential effect on the medicine’s dose accuracy or stability.


Q: How long does Vasten stay in my system after I stop taking it?

Pharmacokinetic data indicates that Vasten is cleared from the body relatively quickly. The half-life, which is the time it takes for half the medicine to leave the bloodstream, is approximately two to three hours. Most of the medication is cleared from the body within half a day.


Q: Can Vasten make my condition worse temporarily?

Vasten is used for long-term health management. If a patient experiences severe symptoms, such as persistent muscle pain, weakness, or unexplained changes in liver enzyme levels, therapy may need to be reviewed. These symptoms are indications of serious adverse reactions and are described as needing urgent medical review.

How should Vasten be stored and disposed of?

Storage Conditions and Environmental Controls

Vasten (pravastatin sodium) must be stored at controlled room temperature, typically 20 C to 25 C. Official labeling emphasizes the need to protect the tablets from moisture and excess heat (Source 1.1). The medication should be kept in the container it was dispensed in, ensuring it remains tightly closed to maintain container integrity and prevent moisture intrusion (Source 4.5). For blister packs, storage must be in the original package (Source 2.5).

Child Safety and Disposal Requirements

All regulatory documents mandate that Vasten must be kept out of the sight and reach of children (Source 3.1). Patients should always engage safety caps and store the container in a secure location (Source 4.4).

Disposal of unused or expired Vasten must be handled in accordance with local requirements for pharmaceutical waste (Source 2.5). Patients should consult a healthcare professional for guidance on how to safely discard medicines that are no longer needed (Source 4.4).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vasten found in:

A-Z Index: